(ALTA) Altarea SCA - Overview
Exchange: PA •
Country: France •
Currency: EUR •
Type: Common Stock •
ISIN: FR0000033219
Stock: Real Estate, Retail Parks, Residential, Offices, Mixed-Use
Total Rating 37
Risk 37
Buy Signal 0.70
Dividends
| Dividend Yield | 1.82% |
| Yield on Cost 5y | 1.81% |
| Yield CAGR 5y | -19.45% |
| Payout Consistency | 76.4% |
| Payout Ratio | - |
| Risk 5d forecast | |
|---|---|
| Volatility | 26.2% |
| Relative Tail Risk | -13.3% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.46 |
| Alpha | 8.35 |
| Character TTM | |
|---|---|
| Beta | -0.025 |
| Beta Downside | 0.262 |
| Drawdowns 3y | |
|---|---|
| Max DD | 42.32% |
| CAGR/Max DD | 0.09 |
Description: ALTA Altarea SCA January 13, 2026
Altarea SCA (ticker ALTA) is positioned as France’s leading developer of low-carbon urban projects, offering end-to-end real-estate services-from design and construction to marketing and asset management. The group operates under several well-known brands and is listed on compartment A of Euronext Paris, classifying it within the Residential REITs sub-industry.
Key quantitative signals (as of FY 2023) include a reported €1.1 bn of total revenue, a net operating income (NOI) margin of roughly 45 %, and an average occupancy rate of 93 % across its residential portfolio. The French REIT sector is currently benefitting from a 3-year average cap-rate compression of 150 bps, driven by low-interest-rate environments and strong demand for sustainable housing. However, rising construction costs (up ~7 % YoY) and tightening financing conditions could pressure margins if not offset by higher rent escalations or ESG-linked premium pricing.
For a deeper, data-driven view of Altarea’s valuation dynamics, you might find ValueRay’s analytical dashboards useful.
Piotroski VR‑10 (Strict, 0-10) 4.5
| Net Income: -336.8m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.05 > 0.02 and ΔFCF/TA 4.24 > 1.0 |
| NWC/Revenue: 9.55% < 20% (prev 30.41%; Δ -20.86% < -1%) |
| CFO/TA 0.06 > 3% & CFO 477.2m > Net Income -336.8m |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 1.21 > 1.5 & < 3 |
| Outstanding Shares: last quarter (22.5m) vs 12m ago 1185 % < -2% |
| Gross Margin: 21.26% > 18% (prev 0.19%; Δ 2107 % > 0.5%) |
| Asset Turnover: 84.77% > 50% (prev 96.33%; Δ -11.56% > 0%) |
| Interest Coverage Ratio: -2.65 > 6 (EBITDA TTM -31.0m / Interest Expense TTM 38.2m) |
Altman Z'' 0.58
| A: 0.06 (Total Current Assets 2.77b - Total Current Liabilities 2.29b) / Total Assets 7.84b |
| B: 0.00 (Retained Earnings 9.50m / Total Assets 7.84b) |
| C: -0.02 (EBIT TTM -101.4m / Avg Total Assets 5.92b) |
| D: 0.27 (Book Value of Equity 1.34b / Total Liabilities 4.88b) |
| Altman-Z'' Score: 0.58 = B |
Beneish M -1.43
| DSRI: 0.77 (Receivables 915.9m/911.1m, Revenue 5.02b/3.86b) |
| GMI: 0.88 (GM 21.26% / 18.71%) |
| AQI: 4.00 (AQ_t 0.61 / AQ_t-1 0.15) |
| SGI: 1.30 (Revenue 5.02b / 3.86b) |
| TATA: -0.10 (NI -336.8m - CFO 477.2m) / TA 7.84b) |
| Beneish M-Score: -1.43 (Cap -4..+1) = D |
What is the price of ALTA shares?
As of February 09, 2026, the stock is trading at EUR 118.80 with a total of 8,783 shares traded.
Over the past week, the price has changed by +2.24%, over one month by +8.39%, over three months by +21.10% and over the past year by +13.42%.
Over the past week, the price has changed by +2.24%, over one month by +8.39%, over three months by +21.10% and over the past year by +13.42%.
Is ALTA a buy, sell or hold?
Altarea SCA has no consensus analysts rating.
What are the forecasts/targets for the ALTA price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 114.5 | -3.6% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 129.8 | 9.3% |
ALTA Fundamental Data Overview February 03, 2026
Market Cap USD = 3.20b (2.71b EUR * 1.1801 EUR.USD)
P/S = 1.0938
P/B = 1.7769
Revenue TTM = 5.02b EUR
EBIT TTM = -101.4m EUR
EBITDA TTM = -31.0m EUR
Long Term Debt = 2.10b EUR (from longTermDebt, last quarter)
Short Term Debt = 297.8m EUR (from shortTermDebt, last quarter)
Debt = 2.51b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 2.15b EUR (from netDebt column, last quarter)
Enterprise Value = 4.86b EUR (2.71b + Debt 2.51b - CCE 357.7m)
Interest Coverage Ratio = -2.65 (Ebit TTM -101.4m / Interest Expense TTM 38.2m)
EV/FCF = 13.04x (Enterprise Value 4.86b / FCF TTM 372.6m)
FCF Yield = 7.67% (FCF TTM 372.6m / Enterprise Value 4.86b)
FCF Margin = 7.42% (FCF TTM 372.6m / Revenue TTM 5.02b)
Net Margin = -6.71% (Net Income TTM -336.8m / Revenue TTM 5.02b)
Gross Margin = 21.26% ((Revenue TTM 5.02b - Cost of Revenue TTM 3.95b) / Revenue TTM)
Gross Margin QoQ = 27.84% (prev 25.98%)
Tobins Q-Ratio = 0.62 (Enterprise Value 4.86b / Total Assets 7.84b)
Interest Expense / Debt = 0.92% (Interest Expense 23.1m / Debt 2.51b)
Taxrate = 4.74% (2.30m / 48.5m)
NOPAT = -96.6m (EBIT -101.4m * (1 - 4.74%)) [loss with tax shield]
Current Ratio = 1.21 (Total Current Assets 2.77b / Total Current Liabilities 2.29b)
Debt / Equity = 1.64 (Debt 2.51b / totalStockholderEquity, last quarter 1.53b)
Debt / EBITDA = -69.34 (negative EBITDA) (Net Debt 2.15b / EBITDA -31.0m)
Debt / FCF = 5.77 (Net Debt 2.15b / FCF TTM 372.6m)
Total Stockholder Equity = 1.41b (last 4 quarters mean from totalStockholderEquity)
RoA = -5.69% (Net Income -336.8m / Total Assets 7.84b)
RoE = -23.97% (Net Income TTM -336.8m / Total Stockholder Equity 1.41b)
RoCE = -2.90% (EBIT -101.4m / Capital Employed (Equity 1.41b + L.T.Debt 2.10b))
RoIC = -2.31% (negative operating profit) (NOPAT -96.6m / Invested Capital 4.17b)
WACC = 3.44% (E(2.71b)/V(5.22b) * Re(5.82%) + D(2.51b)/V(5.22b) * Rd(0.92%) * (1-Tc(0.05)))
Discount Rate = 5.82% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 100.0 | Cagr: 258.3%
[DCF Debug] Terminal Value 80.82% ; FCFF base≈231.8m ; Y1≈152.1m ; Y5≈69.4m
Fair Price DCF = 2.67 (EV 2.21b - Net Debt 2.15b = Equity 62.2m / Shares 23.3m; r=5.90% [WACC]; 5y FCF grow -40.0% → 2.90% )
Revenue Correlation: -51.13 | Revenue CAGR: -21.08% | SUE: 0.24 | # QB: 0
EPS next Year (2026-12-31): EPS=7.83 | Chg30d=-0.599 | Revisions Net=-1 | Growth EPS=+28.1% | Growth Revenue=+5.0%
P/S = 1.0938
P/B = 1.7769
Revenue TTM = 5.02b EUR
EBIT TTM = -101.4m EUR
EBITDA TTM = -31.0m EUR
Long Term Debt = 2.10b EUR (from longTermDebt, last quarter)
Short Term Debt = 297.8m EUR (from shortTermDebt, last quarter)
Debt = 2.51b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 2.15b EUR (from netDebt column, last quarter)
Enterprise Value = 4.86b EUR (2.71b + Debt 2.51b - CCE 357.7m)
Interest Coverage Ratio = -2.65 (Ebit TTM -101.4m / Interest Expense TTM 38.2m)
EV/FCF = 13.04x (Enterprise Value 4.86b / FCF TTM 372.6m)
FCF Yield = 7.67% (FCF TTM 372.6m / Enterprise Value 4.86b)
FCF Margin = 7.42% (FCF TTM 372.6m / Revenue TTM 5.02b)
Net Margin = -6.71% (Net Income TTM -336.8m / Revenue TTM 5.02b)
Gross Margin = 21.26% ((Revenue TTM 5.02b - Cost of Revenue TTM 3.95b) / Revenue TTM)
Gross Margin QoQ = 27.84% (prev 25.98%)
Tobins Q-Ratio = 0.62 (Enterprise Value 4.86b / Total Assets 7.84b)
Interest Expense / Debt = 0.92% (Interest Expense 23.1m / Debt 2.51b)
Taxrate = 4.74% (2.30m / 48.5m)
NOPAT = -96.6m (EBIT -101.4m * (1 - 4.74%)) [loss with tax shield]
Current Ratio = 1.21 (Total Current Assets 2.77b / Total Current Liabilities 2.29b)
Debt / Equity = 1.64 (Debt 2.51b / totalStockholderEquity, last quarter 1.53b)
Debt / EBITDA = -69.34 (negative EBITDA) (Net Debt 2.15b / EBITDA -31.0m)
Debt / FCF = 5.77 (Net Debt 2.15b / FCF TTM 372.6m)
Total Stockholder Equity = 1.41b (last 4 quarters mean from totalStockholderEquity)
RoA = -5.69% (Net Income -336.8m / Total Assets 7.84b)
RoE = -23.97% (Net Income TTM -336.8m / Total Stockholder Equity 1.41b)
RoCE = -2.90% (EBIT -101.4m / Capital Employed (Equity 1.41b + L.T.Debt 2.10b))
RoIC = -2.31% (negative operating profit) (NOPAT -96.6m / Invested Capital 4.17b)
WACC = 3.44% (E(2.71b)/V(5.22b) * Re(5.82%) + D(2.51b)/V(5.22b) * Rd(0.92%) * (1-Tc(0.05)))
Discount Rate = 5.82% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 100.0 | Cagr: 258.3%
[DCF Debug] Terminal Value 80.82% ; FCFF base≈231.8m ; Y1≈152.1m ; Y5≈69.4m
Fair Price DCF = 2.67 (EV 2.21b - Net Debt 2.15b = Equity 62.2m / Shares 23.3m; r=5.90% [WACC]; 5y FCF grow -40.0% → 2.90% )
Revenue Correlation: -51.13 | Revenue CAGR: -21.08% | SUE: 0.24 | # QB: 0
EPS next Year (2026-12-31): EPS=7.83 | Chg30d=-0.599 | Revisions Net=-1 | Growth EPS=+28.1% | Growth Revenue=+5.0%